| ★ |  Berobenatide Monthly GLP-1 Injectable Shows Promise for Weight Loss | | 250 | Estados Unidos | |
| 18 |  Are GLP1’s For Everyone? Which One Is Right For You? | Talking With Docs @talkingwithdocs | 191.9K | Canadá | 88 |
| 10 |  A New Approach To GLP-1s | Metabolic Mind @metabolicmind | 5.6K | Estados Unidos | 89 |
| 12 |  Do GLP-1s Work for Depression—or Is It Metabolism? | Metabolic Mind @metabolicmind | 2.5K | Estados Unidos | 89 |
| 8 |  Survodutide Shows Fat Mass Loss, Liver Fat Reductions in Patients With Obesity Without T2D | | 1.6K | Estados Unidos | 89 |
| 13 |  Retatrutide Provides Substantial Weight Loss in Patients With Obesity or Overweight | | 1.1K | Estados Unidos | 89 |
| 19 |  Retatrutide (The Next Generation GLP 1 Drug) | Dr. Marc Morris @drmarcmorris | 958 | Canadá | 88 |
| 1 |  Inside the VESPER-3 Results: Berobenatide's Weight Loss Potential | | 839 | Estados Unidos | 96 |
| 2 |  GLP-1 Therapies: Where We’ve Been & Where We’re Going | Conversations on Health Care @cohcpodcast | 541 | Estados Unidos | 91 |
| 6 |  Diabetes Dialogue: Retatrutide Phase 3 Data Show Major Weight Loss | | 533 | Estados Unidos | 89 |
| 5 |  GLP-1 Medications for Weight Loss: the Latest Research | DarioHealth @dariohealthwellbeing | 365 | Estados Unidos | 89 |
| 16 |  TRIUMPH-2: Retatrutide Reduces Weight, A1C in Patients With Obesity | | 350 | Estados Unidos | 88 |
| 3 |  SYNCHRONIZE-1: Survodutide Achieves Significant Weight Loss Versus Placebo | | 174 | Estados Unidos | 90 |
| 4 |  Rapid Evolution in GLP-1s and Therapeutics at ADA 2026 | | 171 | Estados Unidos | 89 |
| 11 |  GLP-1s: Miracle Weight Loss or Just Hype? #glp1 #weightlossstrategy #WeightLossDrugs | Live Long and Well With Dr. Bobby @drbobbylivelongandwell | 160 | Estados Unidos | 89 |
| 17 |  Retatrutide Cuts Weight, Cardiovascular Disease Risk in TRIUMPH-3 | | 158 | Estados Unidos | 88 |
| 7 |  Improving GLP-1 Adherence in Patients With Diabetes, With Vivian Fonseca, MD | | 91 | Estados Unidos | 89 |
| 20 |  GLP-1 Discontinuation in Type 2 Diabetes: What Happens When Patients Stop? | | 64 | Estados Unidos | 88 |
| 9 |  #62: GLP-1s: Life-Changing Results… at What Cost? | Live Long and Well With Dr. Bobby @drbobbylivelongandwell | 56 | Estados Unidos | 89 |
| 15 |  GLP-1 use in ALZHEIMER'S. What's the DATA say? #glp1 #alzheimer #insulin | Data Driven Doug @datadrivendoug | 19 | Estados Unidos | 89 |
| 14 |  GLP-1s offer HOPE for ADDICTION recovery #glp1 #addiction #addictionrecovery | Data Driven Doug @datadrivendoug | 14 | Estados Unidos | 89 |